Advancing personalized immunotherapy for melanoma: integrating immunoinformatics in multi-epitope vaccine development, neoantigen identification via NGS, and immune simulation evaluation
The hype hasn't erased the very real worries people have about long-term use, side effects, and the financial toll
Nausea is the most commonly reported symptom with both treatments, particularly during the dose-escalation phase
Colt Clemons Jun 287 min read KPV Peptide: The Anti-Inflammatory Tripeptide Researchers Can't Ignore KPV (Lysine-Proline-Valine) is a tripeptide derived from alpha-MSH and studied for its targeted anti-inflammatory, gut-healing, and immune-modulating properties
10.1016/j.rmed.2016.06.015 Respir Med
Considering that GLP-1R agonists are FDA approved drugs to treat T2DM and also ameliorate NASH, in the present study we evaluated the efficacy of a GLP-1R agonist in two mouse models: one model with NASH-like features (methionine and choline-deficient (MCD) diet), and a second high-fat model of metabolic syndrome and hepatic dysfunction